MATES SHARON (Chairman, President & CEO) reported 2 transactions at INTRA-CELLULAR THERAPIES, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 3/31/2025ACC: 0000950170-25-047937
DirectorOfficer· Chairman, President & CEO
Since Dec 2018
0.00
Net shares
Net seller
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
190K acquired · 190K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−190K
Price / share
—
Trade value
—
% of position
16.7%
3/26/2025
1.14M→945.24K
Common Stock
Indirect
Shares
+190K
Price / share
—
Trade value
—
% of position
New position
3/26/2025
0.00→190K
Total
Net shares
+0.00
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/26/2025 | G · Gift | −190K | — | — | 16.7% | 1.14M | 945.24K |
| Common Stock Indirect | 3/26/2025 | G · Gift | +190K | — | — | New position | 0.00 | 190K |
| Total | +0.00 | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported